FDA NDC Directory · JSON-LD · Markdown

budesonide

NDC 0574-9855 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerPadagis US LLC
Marketing categoryNew Drug Application (innovator) · App NDA021324
Dosage form / routeCAPSULE · ORAL
Active ingredientsBUDESONIDE (3 mg/1)
Marketing started20180629
Package count1

External sources

Source: openFDA. Public-domain (CC0).